# Assessment of Myocardial Injury in Patients Treated With Immune Checkpoint Inhibitors

> **NCT05349058** · — · UNKNOWN · sponsor: **Flinders University** · enrollment: 40 (estimated)

## Conditions studied

- Myocarditis
- Immune Checkpoint Inhibitors
- Cardiotoxicity
- Myocardial Injury

## Interventions

- **DRUG:** Immune Checkpoint Inhibitors

## Key facts

- **NCT ID:** NCT05349058
- **Lead sponsor:** Flinders University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-17
- **Primary completion:** 2023-12-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-04-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05349058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05349058, "Assessment of Myocardial Injury in Patients Treated With Immune Checkpoint Inhibitors". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT05349058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*